CERN Cerner Corporation

Cerner Technology Supports Effort to Safely Reopen HBCUs With Abundant COVID-19 Testing Plans

Cerner Technology Supports Effort to Safely Reopen HBCUs With Abundant COVID-19 Testing Plans

Joins Testing for America to Scale Comprehensive Campus Strategies to Identify and Contain Virus

KANSAS CITY, Mo., Aug. 18, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global health care technology company, announced it has recently joined non-profit and others, including the Thurgood Marshall College Fund (TMCF) and The United Negro College Fund (UNCF), to support Historically Black Colleges and Universities’ (HBCUs) efforts to offer rapid, consistent and affordable COVID-19 testing for students, faculty and staff. Testing for America and its collaborators are helping these academic institutions develop comprehensive reopening safety strategies and linking them to lab partners and other support in the hopes of helping them safety return to classes.

The effort to support HBCUs comes as communities of color around the nation are disproportionately impacted by the economic and health effects of the novel coronavirus. Testing of everyone on campus is one tool in an overall safety plan to help identify and contain the virus, often spread by asymptomatic carriers, and to help the campuses of HBCUs, which will serve a vital role in our nation’s recovery.

Cerner’s interoperable technology can be employed to make sure each COVID-19 test result is reported directly to the student, faculty and staff member, as well as their physicians, for better, seamless medical care coordination and guidance and to all required public health agencies.

“Historically Black Colleges and Universities are a vital part of America’s talent infrastructure,” said Donald Trigg, president, Cerner. “The nationwide effort to provide access to COVID-19 testing holds the promise to be a key pillar of the safe return to campus for these essential institutions. We are excited to have Cerner’s technology help scale this important initiative.”      

About a dozen HBCUs have partnered with Testing for America to work toward safe reopenings this fall. The program is being pioneered at Delaware State University, as recently reported by .

“Robust testing protocols will help give the university community more confidence in coming back and will support our comprehensive approach to reopening,” said Tony Allen, president, Delaware State University. “We want to ensure that the kind of space so many of our students call home is perceived as a safe one, so that they can continue their education without pause."

The COVID-19 pandemic underscores the need for innovative solutions to deliver equitable care across all populations, and Cerner has vowed to use its technologies and leverage data to build a . Cerner’s commitment to diversity and inclusion has been recognized for the past two years by . Last year, Cerner CEO Brent Shafer , uniting leaders from more than 900 companies in a common commitment to advancing diversity and inclusion in the workplace.

About Cerner

Cerner Corporation’s health technologies connect people and information systems in thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit  or connect on , , or . Nasdaq: CERN. Health care is too important to stay the same.

Media Contacts:

Cerner

Stephanie Greenwood, (816) 201-2137,

EN
18/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch